Adhering to Aerosol Therapy Guidelines: Improving Outcomes and Reducing Costs in Indian ICUs

In the intensive care unit (ICU), aerosol therapy compliance remains paramount for effectively managing respiratory conditions. However, non-adherence to established evidence-based guidelines often leads to compromised patient outcomes and increased healthcare expenditures. A recent prospective study in India highlights the economic benefits of following the Indian Guidelines on Nebulization Therapy for adult critically ill patients.

The Current Landscape of Nebulization in Indian ICUs

The research involved 307 adult patients across various tertiary care ICUs over a six-month period. The data revealed that jet nebulizers dominated the device selection, appearing in 91.5% of cases. Clinicians frequently administered bronchodilators (47.13%) and corticosteroids (35%). Interestingly, compliance with drug therapy guidelines varied by ICU category and stay duration. Specifically, drug compliance was notably higher in specialized critical care and neurology units compared to other settings.

Economic Benefits of Aerosol Therapy Compliance

One of the most striking findings of the study is the direct correlation between guideline adherence and cost-effectiveness. Adhering to evidence-based protocols for drug therapy significantly lowered ICU expenditures. Furthermore, administration compliance was higher among patients with non-respiratory diagnoses. These insights suggest that standardized protocols and targeted staff training can bridge the gap between clinical practice and optimal care. Consequently, integrating these guidelines into routine practice is essential for financial sustainability. Moreover, this study provides a clear roadmap for hospitals aiming to optimize their respiratory therapy departments.

Frequently Asked Questions

How does aerosol therapy compliance impact ICU expenditure?

Adherence to evidence-based guidelines reduces the use of unnecessary medications and optimizes delivery methods, leading to a statistically significant reduction in healthcare costs for critically ill patients.

Which nebulizer types are most commonly used in Indian ICUs?

Jet nebulizers are the most common aerosol generators in Indian ICUs, though specialists should ideally tailor the choice of device to the patient’s clinical condition and the specific drug formulation.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional recommendation. Clinicians should use their professional judgment and cross-reference with other sources. Refer to the latest local and national guidelines for clinical practice.

References

Verma AR et al. Compliance of Aerosol Therapy with Evidence-based Guideline and Cost Incurred in Adult Critically-ill Patients: A Prospective Observational Study. Thorac Res Pract. 2026 Mar 05. doi: 10.4274/ThoracResPract.2025.2025-9-8. PMID: 41784010.

Katiyar SK, et al. Indian Guidelines on Nebulization Therapy. Indian J Chest Dis Allied Sci. 2022;64:147-190.

Singhal S, et al. Aerosol drug therapy in critically ill patients (Aero-in-ICU study): A multicentre prospective observational cohort study. Lung India. 2024;41:178-85.